Although, we did explore the mechanism underlying ORR in the 20 patients who showed positive response to the therapy; we speculate that TILs penetrate the tumor microenvironment and secrete IFN-γ, which induces expression of PD-L1 in the tumor cells. The gene discussed is IFNG; the disease is neoplasm.